Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):2–9. doi: 10.1002/pds.1845

Table 2.

Summary of Methods Used to Adjust for Confounding of Measured Variables When Comparing Multiple Drug Exposures

Analytic strategy Method employed in this study
Conventional multivariable model
  • multivariable Cox proportional hazard model that included terms for the exposure variables of interest (3 dummy terms, RSD, CCT, RAL) and a term for each potential confounder

Exposure propensity score (EPS) Single Model EPS
  • created state-specific EPS for RSD, CCT, RAL in full cohort using multinomial logistic regression

  • fit single Cox proportional hazard model adjusting for EPS quintiles (12 dummies, 4 for each drug exposure), stratified by state

Separate Model EPS
  • three contrast cohorts

    1. RSD + ALD

    2. CCT + ALD

    3. RAL + ALD

  • within each contrast cohort

    1. created state-specific EPS using logistic regression (ALD referent/unexposed)

    2. adjusted for EPS quintiles as 4 dummies in Cox proportional hazard model, stratified by state

Disease risk score (DRS) Full Cohort DRS
  • created state-specific DRS equations by including all relevant confounders + exposure of interest

  • calculated individual DRS by multiplying covariate regression coefficients with individual covariate values (exposure variables omitted from equation, i.e., set to zero)

Unexposed DRS
  • same as “full cohort,” however step 1 restricted to unexposed (ALD), and thus exposure variables also not applicable

ALD=alendronate, CCT=nasal calcitonin, RAL=raloxifene, RSD=risedronate

HHS Vulnerability Disclosure